- Home
- BEATW vs BASE Comparison
BEATW vs BASE Comparison
Compare BEATW & BASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEATW
- BASE
- Stock Information
- Founded
- BEATW N/A
- BASE 2011
- Country
- BEATW United States
- BASE United States
- Employees
- BEATW 20
- BASE N/A
- Industry
- BEATW Retail: Computer Software & Peripheral Equipment
- BASE EDP Services
- Sector
- BEATW Technology
- BASE Technology
- Exchange
- BEATW Nasdaq
- BASE Nasdaq
- Market Cap
- BEATW N/A
- BASE N/A
- IPO Year
- BEATW 2021
- BASE 2021
- Fundamental
- Price
- BEATW $0.57
- BASE $16.45
- Analyst Decision
- BEATW
- BASE Buy
- Analyst Count
- BEATW 0
- BASE 14
- Target Price
- BEATW N/A
- BASE $23.00
- AVG Volume (30 Days)
- BEATW N/A
- BASE 394.6K
- Earning Date
- BEATW N/A
- BASE 03-04-2025
- Dividend Yield
- BEATW N/A
- BASE N/A
- EPS Growth
- BEATW N/A
- BASE N/A
- EPS
- BEATW N/A
- BASE N/A
- Revenue
- BEATW N/A
- BASE $204,633,000.00
- Revenue This Year
- BEATW N/A
- BASE $17.76
- Revenue Next Year
- BEATW N/A
- BASE $14.11
- P/E Ratio
- BEATW N/A
- BASE N/A
- Revenue Growth
- BEATW N/A
- BASE 19.27
- 52 Week Low
- BEATW N/A
- BASE $13.53
- 52 Week High
- BEATW N/A
- BASE $32.00
- Technical
- Relative Strength Index (RSI)
- BEATW N/A
- BASE 53.39
- Support Level
- BEATW N/A
- BASE $15.58
- Resistance Level
- BEATW N/A
- BASE $16.41
- Average True Range (ATR)
- BEATW 0.00
- BASE 0.55
- MACD
- BEATW 0.00
- BASE 0.18
- Stochastic Oscillator
- BEATW 0.00
- BASE 74.56
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.